0
0
8/19/22 at 2:03pm
Organization
Labiotech.eu
Author
Omnia Ibrahim
29 words
0
Comments
The startup IgGenix is aiming to re-engineer antibodies that mediate allergic responses into antibodies that can block this response.
You are the first to view
https://www.labiotech.eu/interview/re-engineering-antibodies-prevent-allergies/
Create an account
or login to join the discussion